Atlas Trials

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

Clinical trial NCT06003153 · RECRUITING

Trial details

NCT number
NCT06003153
Sponsor
Massachusetts General Hospital
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Genetic PredispositionMetabolic DiseasesType 2 Diabetes
Start date
2024-03-12
Primary completion
2027-05-31
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.